Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Coteur

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol TreatmentG Coteur
Luminescence : the Journal of Biological and Chemical Luminescence|September 28, 2004
Interaction of metals with peroxidase--mediated luminol-enhanced, chemiluminescence (PLmCL)G Coteur, P Dubois
Progress in Molecular and Subcellular Biology|December 13, 2006
Echinoderm reactive oxygen species (ROS) production measured by peroxidase, luminol-enhanced chemiluminescence (PLCL) as an immunotoxicological toolG Coteur, B Danis, P Dubois
Fish & Shellfish Immunology|December 17, 2003
Environmental factors influencing the immune responses of the common European starfish (Asterias rubens)G Coteur, N Corriere, Ph Dubois
Aquatic Toxicology (Amsterdam, Netherlands)|May 24, 2005
Alteration of cellular immune responses in the seastar Asterias rubens following dietary exposure to cadmiumG Coteur, D Gillan, Ph Pernet, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's diseaseG Coteur, B Feagan, D L Keininger, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2011
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegolB G Feagan, S B Hanauer, G Coteur, et al.
Marine Pollution Bulletin|June 11, 2005
Increased phagocytic activity in contaminated seastars (Asterias rubens) collected in the Southern Bight of the North SeaG Coteur, B Danis, P Wantier, et al.
Marine Biotechnology (New York, N.Y.)|November 17, 2004
Measurement of EROD activity: caution on spectral properties of standards usedG Radenac, G Coteur, B Danis, et al.
Arthritis Care & Research|December 17, 2013
Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyD Gladman, R Fleischmann, G Coteur, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Re-Validation of the Self-Injection Assessment Questionnaire© (Siaqv2.0©) in Rheumatoid Arthritis Patients on Certolizumab Pegol TreatmentG Coteur
Luminescence : the Journal of Biological and Chemical Luminescence|September 28, 2004
Interaction of metals with peroxidase--mediated luminol-enhanced, chemiluminescence (PLmCL)G Coteur, P Dubois
Progress in Molecular and Subcellular Biology|December 13, 2006
Echinoderm reactive oxygen species (ROS) production measured by peroxidase, luminol-enhanced chemiluminescence (PLCL) as an immunotoxicological toolG Coteur, B Danis, P Dubois
Fish & Shellfish Immunology|December 17, 2003
Environmental factors influencing the immune responses of the common European starfish (Asterias rubens)G Coteur, N Corriere, Ph Dubois
Aquatic Toxicology (Amsterdam, Netherlands)|May 24, 2005
Alteration of cellular immune responses in the seastar Asterias rubens following dietary exposure to cadmiumG Coteur, D Gillan, Ph Pernet, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2009
Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's diseaseG Coteur, B Feagan, D L Keininger, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2011
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegolB G Feagan, S B Hanauer, G Coteur, et al.
Marine Pollution Bulletin|June 11, 2005
Increased phagocytic activity in contaminated seastars (Asterias rubens) collected in the Southern Bight of the North SeaG Coteur, B Danis, P Wantier, et al.
Marine Biotechnology (New York, N.Y.)|November 17, 2004
Measurement of EROD activity: caution on spectral properties of standards usedG Radenac, G Coteur, B Danis, et al.
Arthritis Care & Research|December 17, 2013
Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyD Gladman, R Fleischmann, G Coteur, et al.
Pageof 2